The lessons of COVID-19, SARS, and MERS: Implications for preventive strategies

2022

Closed access Metadata (CSL-JSON)
DOI 10.1080/20479700.2022.2051126
Data confidence 85 high
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

There was a dramatic spread of three novel coronaviruses (CoVs) – severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and SARS-CoV-2 – from the beginning of the twenty-first century. All three infections share similar pathogenesis and clinical presentation, and human-to-human transmission is the most frequent transmission mode for all three CoVs, which spread through respiratory droplets, by direct contact with contaminated surfaces or by inhaling aerosols. Nosocomial transmission plays a major role for SARS-CoV and MERS-CoV but appears to be less critical for SARS-CoV-2. Coronaviruses will very likely continue to be a source of new acute respiratory infections in the future. This is why it is needed to better understand the whole spectrum of factors that underlie CoV disease outbreaks. Although a search for specific treatment and vaccine development has to be continued, a strategic preparedness and plan of action should be envisaged in advance. This review discusses the current knowledge of SARS-CoV, MERS-CoV, SARS-CoV-2 epidemiological determinants and emphasizes public health interventions that could help in the fight against them.